Industry Focus Transcripts

The cutting-edge technology of yesterday is now available to mom-and-pop shops, and the big guys will have to step up their game to stand out.

The company's $16 billion bid for a majority stake in the leading Indian e-commerce company is paving the way for a decades-long future.

They rose through the ranks over two decades and now hold the reins to two industry titans.

The bricks and mortar retail leader has bought an upstart digital player while Time Warner has invested in a service it has been critical of.

Tech companies have managed to see good momentum.

From smaller, super-dense batteries to state-of-the-art navigation technologies, discover how these companies are changing the sector.

There's some controversy here.

DIscussing a new IPO in the consumer goods space that focuses on enhancing the creativity of its users.

The holidays are a popular time to get engaged.

With staggering growth and huge opportunity ahead, this is one you don’t want to miss.

How we shop, what we buy, and even what we think about brands has shifted significantly this year, and some companies were better-prepared for the changes than others.

Our hosts take a closer look at one of the most successful companies in the e-commerce space.

Companies have quietly hyped up customization, and consumers have gotten used to services tailored to their specific needs.

From the shoes on your feet to your daily dose of caffeine, many consumer and retail companies are giving people the opportunity to add a flair of customization to the products they buy, generating growth and brand loyalty in the process.

DreamWorks founder and CEO Jeffrey Katzenberg called the buyout of the company, at $3.8 billion, “the deal I’d always hoped would come along.” But after a major restructuring and string of box-office disappointments for the animation studio, is Comcast getting a good deal?

In this episode of Industry Focus, The Motley Fool’s Gaby Lapera and John Maxfield give an overview of the history of banking in America.

Here are most important factors to consider when you’re deciding when to draw on your benefits.

A jury says Gilead owes Merck & Co. and Ionis Pharmaceuticals a pretty hefty sum for violating their patents, but this verdict (if upheld) is only liable to move the stock-price needle for one of them.

Some things never change -- and in healthcare, we sometimes feel like we’re talking about the same stuff year in and year out. Join us as we cover some stories that were a big deal in 2014, check in on how they’re going now, and predict some major trends in 2018.

What we got right and what we got incredibly wrong in our predictions for the energy sector two years ago.